Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / Common stock ("Common Shares")
-
Shares outstanding
-
212,883,456
-
Total 13F shares
-
41,528,139
-
Share change
-
-3,146,389
-
Total reported value
-
$289,118,916
-
Put/Call ratio
-
101%
-
Price per share
-
$6.97
-
Number of holders
-
137
-
Value change
-
-$36,286,646
-
Number of buys
-
74
-
Number of sells
-
66
Institutional Holders of OCULAR THERAPEUTIX, INC - Common stock ("Common Shares") (OCUL) as of Q4 2021
As of 31 Dec 2021,
OCULAR THERAPEUTIX, INC - Common stock ("Common Shares") (OCUL) was held by
137 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
41,528,139 shares.
The largest 10 holders included
Opaleye Management Inc., SUMMER ROAD LLC, BlackRock Inc., VANGUARD GROUP INC, DELTEC ASSET MANAGEMENT LLC, STATE STREET CORP, CITADEL ADVISORS LLC, GEODE CAPITAL MANAGEMENT, LLC, EMERALD ADVISERS, LLC, and EMERALD MUTUAL FUND ADVISERS TRUST.
This page lists
137
institutional shareholders reporting positions in this security
for the Q4 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.